Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

PaperCitations, authors & open-access status

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 615 citations, 2018 year and green oa status.

615
Citations
2018
Year
green
OA Status

Related on ScholarIQ

Johan Richter
Author
The Lancet Oncology
Journal
Chronic Myeloid Leukemia Treatments
Topic
Chronic Myeloid Leukemia Treatments
Topic
Lung Cancer Treatments and Mutations
Topic
Acute Myeloid Leukemia Research
Topic
470M+ articles · free account